News

Summit Therapeutics Ivonescimab Shows Overall Survival Benefit in Lung Cancer, ASCO 2026 Plenary Data Expected

Non-Small Cell Lung Cancer (NSCLC) · 3 min

AC Immune Advances ACI-24 Alzheimer's Trial to Final Cohort, Initiates ACI-19764 Phase 1 Study

2 min

Addex Advances Dipraglurant for Brain Injury Recovery, Reports 2025 Financial Results

3 min

AC Immune Initiates Final Cohort in Phase 1b/2 ABATE Trial for Anti-Abeta Alzheimer's Treatment

3 min

Mabwell 9MW2821 Cervical Cancer Data to Be Presented at ESMO GC 2026 Conference

2 min

Aquestive Therapeutics Faces Securities Fraud Lawsuit Despite Anaphylm FDA Review Progress

Emergency Medicine/Allergy · 3 min

FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer

FDA · Oncology - Prostate Cancer · 3 min

Eli Lilly's Foundayo (Orforglipron) Receives FDA Approval for Obesity Treatment as Company Reports Strong Q1 2026 Results

Metabolic disorders and oncology · 3 min

Theradaptive Receives FDA Approval for Pivotal Phase 3 Trial of OsteoAdapt SP in Spinal Fusion

FDA · 2 min

Pharma Partnering US: $77.3B Licensing Deals in Q1 2026

biotech · 12 min

Fierce Biotech Week 2026: AI & Oncology Pipeline Recap

biotech · 5 min

IPEC Excipient World Biologics Summit 2026: Recap

general · 3 min